CytoDyn Raises $5 Million in Private Share Placement

PUBT · 3d ago
CytoDyn Raises $5 Million in Private Share Placement
  • CytoDyn raised $5 million through a private investment from an existing investor.
  • The common share purchase price was $0.24, with no accompanying warrants.
  • Proceeds will support leronlimab development in colorectal cancer, earlier treatment settings and other solid tumors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoDyn Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611120830PRIMZONEFULLFEED9876160) on November 12, 2026, and is solely responsible for the information contained therein.